Drug manufacturing supporting malaria research

Active Definitive Contract Awarded Last action

Contract number
W81XWH18C0021
Awardee
Awarding agency
Obligated
$185,566

Award facts

Opportunity
Contract value 100% obligated
$185,565.94 Current and potential, with all options
Completion date 90% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Not Competed · 1 offer Only One Source
Pricing
Firm Fixed Price
Place of performance
Painesville, OH 44077, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Terminate for Convenience P00003 · Triazine drug manufacturing for malaria vaccine for the wrair, silver spring, MD. Termination for convenience due to research findings did not show viability. -$269,434
Other Administrative Action P00002 · Antimalarial drug research - work stop order modification. $0
Supplemental Agreement for work within scope P00001 · Research and development trazine drug manufacturing and stability $0
Original award $455,000

About this award

The Department of the Army Medical Command awarded a Definitive, Firm Fixed Price contract to Olon Ricerca Bioscience LLC, a foreign-owned, for-profit organization, to provide drug manufacturing services in support of malaria research. The contract has a potential value of $185,565.94 and a completion date of October 17, 2027. The contract is not associated with a set-aside designation.

Quick answers

Who was awarded contract W81XWH18C0021?

W81XWH18C0021 was awarded to Olon USA LLC by Medical Command (Department of the Army) on October 18, 2017.

How much is contract W81XWH18C0021 worth?

The government has obligated $185,566 on W81XWH18C0021.

Was contract W81XWH18C0021 competed?

The extent of competition for W81XWH18C0021 was not competed. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award